Association between immune-related adverse event timing and treatment outcomes.

Oncoimmunology · 2022 · PMC8741287 · PMID 35003896

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a near-significant trendno p-value reported

In both the UTSW and Global cohort, there was a near-significant trend association with greater OS among patients with late-onset irAE compared to patients with early-onset irAE by the 6-month landmark time (UTSW cohort, HR 0.55, 95% CI, 0.25–1.24; P = .15; Global cohort, HR 0.49, 95% CI, 0.26–0.91; P = .06) (Supplementary Figure 2 ).

also in 290 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.